Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Improvement with infliximab of a disseminated sarcoidosis in a patient with Crohn's disease

Abstract : Sarcoidosis and Crohn's disease are systemic granulomatous disorders affecting the lung and the intestine, respectively, with variable involvement of other organs and are seldom associated. While anti-TNF alpha is a recognized treatment of Crohn's disease, its usage is discussed in sarcoidosis. A 42-year-old man presented with an 11-year-long history of Crohn's disease; upon discovery of an abnormal chest CT scan the diagnosis of multivisceral sarcoidosis was made and, later, a treatment with an anti-TNF alpha agent, infliximab, was started, because of worsening Crohn's disease recurrences. CT scan demonstrated net regression of pulmonary opacities and hepatosplenic lesions. Pathologies obtained from the intestinal tract and the bronchi of the patient were, respectively, characteristic of Crohn's disease and sarcoidosis leading to the diagnosis of both diseases. We report a rare case of steroid resistant Crohn's disease associated with multivisceral sarcoidosis, treated successfully by an anti-TNF alpha agent, infliximab.
Type de document :
Article dans une revue
Liste complète des métadonnées
Déposant : Marie-Gabrielle Chautard <>
Soumis le : mercredi 24 juillet 2019 - 10:56:01
Dernière modification le : vendredi 18 septembre 2020 - 14:35:03

Lien texte intégral




N. Chebib, Fabrice Piegay, Julie Traclet, F. Mion, Jean-François Mornex. Improvement with infliximab of a disseminated sarcoidosis in a patient with Crohn's disease. Case Reports in Pulmonology, 2014, 2014, pp.368780. ⟨10.1155/2014/368780⟩. ⟨hal-02192926⟩



Consultations de la notice